News and Analysis

Kyverna Therapeutics rallies $85m Series B

Kyverna Therapeutics, a cell therapy company, has secured $85 million in Series B financing.

-

Kyverna Therapeutics, a cell therapy company, has secured $85 million in Series B financing. Northpond Ventures led the round.

Source: Press Release